• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Endocrinology and Metabolism Clinics of North America >Screening for adrenal-endocrine hypertension: overview of accuracy and cost-effectiveness.
【24h】

Screening for adrenal-endocrine hypertension: overview of accuracy and cost-effectiveness.

机译：肾上腺内分泌高血压的筛查：准确性和成本效益概述。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Formal studies have not been performed to assess the cost-effectiveness of screening strategies for endocrine causes of hypertension. However, an understanding of the diagnostic accuracy of available screening tests and the clinical settings where disease identification will lead to improved health outcomes form the basis for a cost-effective strategy. Primary aldosteronism screening should be selective and restricted to settings where knowledge of the diagnosis has the greatest chance of improving health outcomes. Pheochromocytoma is rare; however, because it is a potentially fatal disease, screening strategies should err on the side of not missing the diagnosis, especially in high-risk clinical settings.
机译：尚未进行正式的研究来评估内分泌原因引起的高血压筛查策略的成本效益。但是，对可用筛查测试的诊断准确性以及疾病识别将导致改善健康状况的临床设置的了解，构成了具有成本效益的策略的基础。初级醛固酮增多症筛查应该是选择性的，并且应限于诊断知识最有可能改善健康结果的环境。嗜铬细胞瘤罕见;但是，由于它是潜在的致命疾病，因此应在不漏诊的情况下进行筛查，尤其是在高风险的临床环境中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号